Kexon SINOVAC announced that the Antigua High Court has ruled that Simon Anderson, Fu Shan, Jiao Shuge, Lu Yulin, Qiu Yumin, Wang Yu, Yan Yan, and Yin Weidong formed the company's board of directors to perform the duties of the company's board of directors until the 2025 Special Shareholders' Meeting dispute trial. The ruling of the High Court of Antigua stemmed from a hearing held on October 27, 2025. At the hearing, Saifu Fund, Aobo Capital, and Qiangxin Capital each applied to the court for an injunction, requesting confirmation of their respective board composition before the court makes a final ruling on the dispute over the results of the company's special shareholders' meeting to be held on July 8, 2025. The High Court of Antigua has scheduled the formal hearing of the shareholders' meeting dispute from late April to early May 2026, and the court will decide after the trial is over. The board of directors held a board meeting on December 17, 2025, and reiterated that the board of directors will push for the resumption of trading of Kexon shares on NASDAQ and facilitate all parties concerned to resolve differences and reach a settlement to ensure the stability of the company's operations.

Kexon SINOVAC announced that the Antigua High Court has ruled that Simon Anderson, Fu Shan, Jiao Shuge, Lu Yulin, Qiu Yumin, Wang Yu, Yan Yan, and Yin Weidong formed the company's board of directors to perform the duties of the company's board of directors until the 2025 Special Shareholders' Meeting dispute trial. The ruling of the High Court of Antigua stemmed from a hearing held on October 27, 2025. At the hearing, Saifu Fund, Aobo Capital, and Qiangxin Capital each applied to the court for an injunction, requesting confirmation of their respective board composition before the court makes a final ruling on the dispute over the results of the company's special shareholders' meeting to be held on July 8, 2025. The High Court of Antigua has scheduled the formal hearing of the shareholders' meeting dispute from late April to early May 2026, and the court will decide after the trial is over. The board of directors held a board meeting on December 17, 2025, and reiterated that the board of directors will push for the resumption of trading of Kexon shares on NASDAQ and facilitate all parties concerned to resolve differences and reach a settlement to ensure the stability of the company's operations.